呼吸器生物製剤の世界市場に関する洞察、2030年までの予測

当レポートは、呼吸器生物製剤 (Respiratory Biologics) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

• 呼吸器生物製剤の製品概要
• 市場：タイプ別
  • 世界の呼吸器生物製剤の市場規模成長率：タイプ別, 2019 VS 2023 VS 2030
  • Intravenous
  • Subcuteneous
• 市場：用途別
  • 世界の呼吸器生物製剤の市場規模成長率：用途別, 2019 VS 2023 VS 2030
  • Asthma
  • Chronic Rhinosinasitis
  • Hypereosinophilic Syndrome
  • Other
• 前提条件と制限
• 調査目的
• 対象期間

第2章 レポート概要

• 世界の呼吸器生物製剤の収益 推定および予測 2019-2030
• 世界の呼吸器生物製剤の収益：地域別
  • 世界の呼吸器生物製剤の収益：地域別: 2019 VS 2023 VS 2030
  • 世界の呼吸器生物製剤の収益：地域別 (2019-2024)
  • 世界の呼吸器生物製剤の収益：地域別 (2025-2030)
  • 世界の呼吸器生物製剤の収益市場シェア 地域別 (2019-2030)
• 世界の呼吸器生物製剤 売上予測・予想 2019-2030
• 世界の呼吸器生物製剤の販売：地域別
  • 世界の呼吸器生物製剤の販売：地域別: 2019 VS 2023 VS 2030
  • 世界の呼吸器生物製剤の販売：地域別 (2019-2024)
  • 世界の呼吸器生物製剤の販売：地域別 (2025-2030)
  • 世界の呼吸器生物製剤の販売市場シェア 地域別 (2019-2030)
• 米国・カナダ
• 欧州
• 中国
• アジア（中国を除く）
• 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

• 世界の呼吸器生物製剤の販売：企業別
  • 世界の呼吸器生物製剤の販売：企業別 (2019-2024)
  • 世界の呼吸器生物製剤の販売市場シェア：企業別 (2019-2024)
  • 世界の上位10・上位5企業： 呼吸器生物製剤 in 2023
• 世界の呼吸器生物製剤の収益：企業別
  • 世界の呼吸器生物製剤の収益：企業別 (2019-2024)
  • 世界の呼吸器生物製剤の収益市場シェア：企業別 (2019-2024)
  • 世界の上位10・上位5企業： 呼吸器生物製剤の収益 2023
• 世界の主要企業 呼吸器生物製剤, 業界ランキング, 2021 VS 2022
• 世界の呼吸器生物製剤の販売価格：企業別 (2019-2024)
• 競合情勢の分析
  • 企業の市場集中度 (CR5 and HHI)
  • 世界の呼吸器生物製剤の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
• 世界の主要メーカー 呼吸器生物製剤, 製造拠点分布と本社
• 世界の主要メーカー 呼吸器生物製剤, 提供製品と用途
• 世界の主要メーカー 呼吸器生物製剤, 業界参入時期
• M&A, 拡張計画

第4章 市場規模：タイプ別

• 世界の呼吸器生物製剤の販売：タイプ別
  • 世界の呼吸器生物製剤の販売実績：タイプ別 (2019-2024)
  • 世界の呼吸器生物製剤の販売予測：タイプ別 (2025-2030)
  • 世界の呼吸器生物製剤の販売市場シェア：タイプ別 (2019-2030)
• 世界の呼吸器生物製剤 収益：タイプ別
  • 世界の呼吸器生物製剤の収益実績：タイプ別 (2019-2024)
  • 世界の呼吸器生物製剤の収益予測：タイプ別 (2025-2030)
  • 世界の呼吸器生物製剤の収益市場シェア：タイプ別 (2019-2030)
• 世界の呼吸器生物製剤の価格：タイプ別
  • 世界の呼吸器生物製剤の価格：タイプ別 (2019-2024)
  • 世界の呼吸器生物製剤の価格予測：タイプ別 (2025-2030)

第5章 市場規模：用途別

• 世界の呼吸器生物製剤の販売：用途別
  • 世界の呼吸器生物製剤の販売実績：用途別 (2019-2024)
  • 世界の呼吸器生物製剤の販売予測：用途別 (2025-2030)
  • 世界の呼吸器生物製剤の販売市場シェア：用途別 (2019-2030)
• 世界の呼吸器生物製剤の収益：用途別
  • 世界の呼吸器生物製剤の収益実績：用途別 (2019-2024)
  • 世界の呼吸器生物製剤の収益予測：用途別 (2025-2030)
  • 世界の呼吸器生物製剤の収益市場シェア：用途別 (2019-2030)
• 世界の呼吸器生物製剤の価格：用途別
  • 世界の呼吸器生物製剤の価格：用途別 (2019-2024)
  • 世界の呼吸器生物製剤の価格予測：用途別 (2025-2030)

第6章 米国・カナダ

• 米国・カナダ 呼吸器生物製剤 市場規模：タイプ別
  • 米国・カナダ 呼吸器生物製剤の販売：タイプ別 (2019-2030)
  • 米国・カナダ 呼吸器生物製剤 収益：タイプ別 (2019-2030)
• 米国・カナダ 呼吸器生物製剤 市場規模：用途別
  • 米国・カナダ 呼吸器生物製剤の販売：用途別 (2019-2030)
  • 米国・カナダ 呼吸器生物製剤の収益：用途別 (2019-2030)
• 米国・カナダ 呼吸器生物製剤 市場規模：国別
  • 米国・カナダ 呼吸器生物製剤の収益：国別: 2019 VS 2023 VS 2030
  • 米国・カナダ 呼吸器生物製剤の収益：国別 (2019-2030)
  • 米国・カナダ 呼吸器生物製剤の販売：国別 (2019-2030)
  • US
  • カナダ

第7章 欧州

• 欧州の呼吸器生物製剤 市場規模：タイプ別
  • 欧州の呼吸器生物製剤の販売：タイプ別 (2019-2030)
  • 欧州の呼吸器生物製剤 収益：タイプ別 (2019-2030)
• 欧州の呼吸器生物製剤 市場規模：用途別
  • 欧州の呼吸器生物製剤の販売：用途別 (2019-2030)
  • 欧州の呼吸器生物製剤の収益：用途別 (2019-2030)
• 欧州の呼吸器生物製剤 市場規模：国別
  • 欧州の呼吸器生物製剤の収益：国別: 2019 VS 2023 VS 2030
  • 欧州の呼吸器生物製剤の収益：国別 (2019-2030)
  • 欧州の呼吸器生物製剤の販売：国別 (2019-2030)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア

第8章 中国

• 中国の呼吸器生物製剤 市場規模：タイプ別
  • 中国の呼吸器生物製剤の販売：タイプ別 (2019-2030)
  • 中国の呼吸器生物製剤 収益：タイプ別 (2019-2030)
• 中国の呼吸器生物製剤 市場規模：用途別
  • 中国の呼吸器生物製剤の販売：用途別 (2019-2030)
  • 中国の呼吸器生物製剤の収益：用途別 (2019-2030)

第9章 アジア（中国を除く）

• アジア地域 呼吸器生物製剤 市場規模：タイプ別
  • アジア地域 呼吸器生物製剤の販売：タイプ別 (2019-2030)
  • アジア地域 呼吸器生物製剤 収益：タイプ別 (2019-2030)
• アジア地域 呼吸器生物製剤 市場規模：用途別
  • アジア地域 呼吸器生物製剤の販売：用途別 (2019-2030)
  • アジア地域 呼吸器生物製剤の収益：用途別 (2019-2030)
• アジア地域 呼吸器生物製剤 市場規模：地域別
  • アジア地域 呼吸器生物製剤の収益：地域別: 2019 VS 2023 VS 2030
  • アジア地域 呼吸器生物製剤の収益：地域別 (2019-2030)
  • アジア地域 呼吸器生物製剤の販売：地域別 (2019-2030)
  • 日本
  • 韓国
  • 台湾
  • 東南アジア
  • インド
  • オーストラリア

第10章 中東, アフリカ ・ラテンアメリカ

• 中東, アフリカ ・ラテンアメリカの呼吸器生物製剤 市場規模：タイプ別
  • 中東, アフリカ ・ラテンアメリカの呼吸器生物製剤の販売：タイプ別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの呼吸器生物製剤 収益：タイプ別 (2019-2030)
• 中東, アフリカ ・ラテンアメリカの呼吸器生物製剤 市場規模：用途別
  • 中東, アフリカ ・ラテンアメリカの呼吸器生物製剤の販売：用途別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの呼吸器生物製剤の収益：用途別 (2019-2030)
• 中東, アフリカ ・ラテンアメリカの呼吸器生物製剤 市場規模：国別
  • 中東, アフリカ ・ラテンアメリカの呼吸器生物製剤の収益：国別: 2019 VS 2023 VS 2030
  • 中東, アフリカ ・ラテンアメリカの呼吸器生物製剤の収益：国別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの呼吸器生物製剤の販売：国別 (2019-2030)
  • ブラジル
  • メキシコ
  • トルコ
  • イスラエル
  • 湾岸協力理事会諸国

第11章 企業プロファイル

• GSK
• AstraZeneca
• Sanofi
• Genentech USA
• Teva Respiratory
• Novartis
• Roche
• Boehringer Ingelheim
• Regeneron Pharmaceuticals
• Merck
• Johnson & Johnson
• Amgen
• Biogen
• Vertex Pharmaceuticals
• AbbVie

第12章 業界チェーンと販売チャネルの分析

• 呼吸器生物製剤 業界チェーン分析
• 呼吸器生物製剤 主要原材料
  • 主要原材料
  • 原材料の主要サプライヤー
• 呼吸器生物製剤 生産形態とプロセス
• 呼吸器生物製剤 販売およびマーケティング
  • 呼吸器生物製剤 販売チャネルs
  • 呼吸器生物製剤 卸業者
• 呼吸器生物製剤 顧客

第13章 呼吸器生物製剤 市場動向

• 呼吸器生物製剤 業界動向
• 呼吸器生物製剤 市場の促進要因
• 呼吸器生物製剤 市場の課題
• 呼吸器生物製剤 市場の抑制要因

第14章 主な調査結果 世界の呼吸器生物製剤の主な市場調査結果

第15章 付録

List of Tables

Table 1. Global Respiratory Biologics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Intravenous

Table 3. Major Manufacturers of Subcuteneous

Table 4. Global Respiratory Biologics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Respiratory Biologics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Respiratory Biologics Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Respiratory Biologics Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Respiratory Biologics Revenue Market Share by Region (2019-2024)

Table 9. Global Respiratory Biologics Revenue Market Share by Region (2025-2030)

Table 10. Global Respiratory Biologics Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 11. Global Respiratory Biologics Sales by Region (2019-2024) & (K Units)

Table 12. Global Respiratory Biologics Sales by Region (2025-2030) & (K Units)

Table 13. Global Respiratory Biologics Sales Market Share by Region (2019-2024)

Table 14. Global Respiratory Biologics Sales Market Share by Region (2025-2030)

Table 15. Global Respiratory Biologics Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Respiratory Biologics Sales Share by Manufacturers (2019-2024)

Table 17. Global Respiratory Biologics Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Respiratory Biologics Revenue Market Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Respiratory Biologics, Industry Ranking, 2021 VS 2022 VS 2023

Table 20. Respiratory Biologics Price by Manufacturers (2019-2024) & (US$/Unit)

Table 21. Global Respiratory Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Respiratory Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Biologics as of 2023)

Table 23. Global Key Manufacturers of Respiratory Biologics, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Respiratory Biologics, Product Offered and Application

Table 25. Global Key Manufacturers of Respiratory Biologics, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Respiratory Biologics Sales by Type (2019-2024) & (K Units)

Table 28. Global Respiratory Biologics Sales by Type (2025-2030) & (K Units)

Table 29. Global Respiratory Biologics Sales Share by Type (2019-2024)

Table 30. Global Respiratory Biologics Sales Share by Type (2025-2030)

Table 31. Global Respiratory Biologics Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Respiratory Biologics Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Respiratory Biologics Revenue Share by Type (2019-2024)

Table 34. Global Respiratory Biologics Revenue Share by Type (2025-2030)

Table 35. Respiratory Biologics Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Respiratory Biologics Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Respiratory Biologics Sales by Application (2019-2024) & (K Units)

Table 38. Global Respiratory Biologics Sales by Application (2025-2030) & (K Units)

Table 39. Global Respiratory Biologics Sales Share by Application (2019-2024)

Table 40. Global Respiratory Biologics Sales Share by Application (2025-2030)

Table 41. Global Respiratory Biologics Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Respiratory Biologics Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Respiratory Biologics Revenue Share by Application (2019-2024)

Table 44. Global Respiratory Biologics Revenue Share by Application (2025-2030)

Table 45. Respiratory Biologics Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Respiratory Biologics Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Respiratory Biologics Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Respiratory Biologics Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Respiratory Biologics Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Respiratory Biologics Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Respiratory Biologics Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Respiratory Biologics Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Respiratory Biologics Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Respiratory Biologics Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Respiratory Biologics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Respiratory Biologics Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Respiratory Biologics Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Respiratory Biologics Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Respiratory Biologics Sales by Country (2025-2030) & (K Units)

Table 60. Europe Respiratory Biologics Sales by Type (2019-2024) & (K Units)

Table 61. Europe Respiratory Biologics Sales by Type (2025-2030) & (K Units)

Table 62. Europe Respiratory Biologics Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Respiratory Biologics Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Respiratory Biologics Sales by Application (2019-2024) & (K Units)

Table 65. Europe Respiratory Biologics Sales by Application (2025-2030) & (K Units)

Table 66. Europe Respiratory Biologics Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Respiratory Biologics Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Respiratory Biologics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Respiratory Biologics Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Respiratory Biologics Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Respiratory Biologics Sales by Country (2019-2024) & (K Units)

Table 72. Europe Respiratory Biologics Sales by Country (2025-2030) & (K Units)

Table 73. China Respiratory Biologics Sales by Type (2019-2024) & (K Units)

Table 74. China Respiratory Biologics Sales by Type (2025-2030) & (K Units)

Table 75. China Respiratory Biologics Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Respiratory Biologics Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Respiratory Biologics Sales by Application (2019-2024) & (K Units)

Table 78. China Respiratory Biologics Sales by Application (2025-2030) & (K Units)

Table 79. China Respiratory Biologics Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Respiratory Biologics Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Respiratory Biologics Sales by Type (2019-2024) & (K Units)

Table 82. Asia Respiratory Biologics Sales by Type (2025-2030) & (K Units)

Table 83. Asia Respiratory Biologics Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Respiratory Biologics Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Respiratory Biologics Sales by Application (2019-2024) & (K Units)

Table 86. Asia Respiratory Biologics Sales by Application (2025-2030) & (K Units)

Table 87. Asia Respiratory Biologics Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Respiratory Biologics Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Respiratory Biologics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Respiratory Biologics Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Respiratory Biologics Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Respiratory Biologics Sales by Region (2019-2024) & (K Units)

Table 93. Asia Respiratory Biologics Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Respiratory Biologics Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Respiratory Biologics Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Respiratory Biologics Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Respiratory Biologics Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Respiratory Biologics Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Respiratory Biologics Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Respiratory Biologics Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Respiratory Biologics Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Respiratory Biologics Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Respiratory Biologics Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Respiratory Biologics Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Respiratory Biologics Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Respiratory Biologics Sales by Country (2025-2030) & (K Units)

Table 107. GSK Company Information

Table 108. GSK Description and Major Businesses

Table 109. GSK Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. GSK Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. GSK Recent Developments

Table 112. AstraZeneca Company Information

Table 113. AstraZeneca Description and Major Businesses

Table 114. AstraZeneca Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. AstraZeneca Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. AstraZeneca Recent Developments

Table 117. Sanofi Company Information

Table 118. Sanofi Description and Major Businesses

Table 119. Sanofi Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Sanofi Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Sanofi Recent Developments

Table 122. Genentech USA Company Information

Table 123. Genentech USA Description and Major Businesses

Table 124. Genentech USA Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Genentech USA Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Genentech USA Recent Developments

Table 127. Teva Respiratory Company Information

Table 128. Teva Respiratory Description and Major Businesses

Table 129. Teva Respiratory Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Teva Respiratory Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Teva Respiratory Recent Developments

Table 132. Novartis Company Information

Table 133. Novartis Description and Major Businesses

Table 134. Novartis Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Novartis Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Novartis Recent Developments

Table 137. Roche Company Information

Table 138. Roche Description and Major Businesses

Table 139. Roche Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 140. Roche Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Roche Recent Developments

Table 142. Boehringer Ingelheim Company Information

Table 143. Boehringer Ingelheim Description and Major Businesses

Table 144. Boehringer Ingelheim Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 145. Boehringer Ingelheim Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Boehringer Ingelheim Recent Developments

Table 147. Regeneron Pharmaceuticals Company Information

Table 148. Regeneron Pharmaceuticals Description and Major Businesses

Table 149. Regeneron Pharmaceuticals Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 150. Regeneron Pharmaceuticals Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Regeneron Pharmaceuticals Recent Developments

Table 152. Merck Company Information

Table 153. Merck Description and Major Businesses

Table 154. Merck Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 155. Merck Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Merck Recent Developments

Table 157. Johnson & Johnson Company Information

Table 158. Johnson & Johnson Description and Major Businesses

Table 159. Johnson & Johnson Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 160. Johnson & Johnson Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Johnson & Johnson Recent Developments

Table 162. Amgen Company Information

Table 163. Amgen Description and Major Businesses

Table 164. Amgen Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 165. Amgen Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. Amgen Recent Developments

Table 167. Biogen Company Information

Table 168. Biogen Description and Major Businesses

Table 169. Biogen Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 170. Biogen Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 171. Biogen Recent Developments

Table 172. Vertex Pharmaceuticals Company Information

Table 173. Vertex Pharmaceuticals Description and Major Businesses

Table 174. Vertex Pharmaceuticals Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 175. Vertex Pharmaceuticals Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 176. Vertex Pharmaceuticals Recent Developments

Table 177. AbbVie Company Information

Table 178. AbbVie Description and Major Businesses

Table 179. AbbVie Respiratory Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 180. AbbVie Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications

Table 181. AbbVie Recent Developments

Table 182. Key Raw Materials Lists

Table 183. Raw Materials Key Suppliers Lists

Table 184. Respiratory Biologics Distributors List

Table 185. Respiratory Biologics Customers List

Table 186. Respiratory Biologics Market Trends

Table 187. Respiratory Biologics Market Drivers

Table 188. Respiratory Biologics Market Challenges

Table 189. Respiratory Biologics Market Restraints

Table 190. Research Programs/Design for This Report

Table 191. Key Data Information from Secondary Sources

Table 192. Key Data Information from Primary Sources

List of Figures

Figure 1. Respiratory Biologics Product Picture

Figure 2. Global Respiratory Biologics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Respiratory Biologics Market Share by Type: 2023 & 2030

Figure 4. Intravenous Product Picture

Figure 5. Subcuteneous Product Picture

Figure 6. Global Respiratory Biologics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Respiratory Biologics Market Share by Application: 2023 & 2030

Figure 8. Asthma

Figure 9. Chronic Rhinosinasitis

Figure 10. Hypereosinophilic Syndrome

Figure 11. Other

Figure 12. Respiratory Biologics Report Years Considered

Figure 13. Global Respiratory Biologics Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 15. Global Respiratory Biologics Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 16. Global Respiratory Biologics Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 17. Global Respiratory Biologics Revenue Market Share by Region (2019-2030)

Figure 18. Global Respiratory Biologics Sales (2019-2030) & (K Units)

Figure 19. Global Respiratory Biologics Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 20. Global Respiratory Biologics Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Respiratory Biologics Sales YoY (2019-2030) & (K Units)

Figure 22. US & Canada Respiratory Biologics Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Respiratory Biologics Sales YoY (2019-2030) & (K Units)

Figure 24. Europe Respiratory Biologics Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Respiratory Biologics Sales YoY (2019-2030) & (K Units)

Figure 26. China Respiratory Biologics Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Respiratory Biologics Sales YoY (2019-2030) & (K Units)

Figure 28. Asia (excluding China) Respiratory Biologics Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Respiratory Biologics Sales YoY (2019-2030) & (K Units)

Figure 30. Middle East, Africa and Latin America Respiratory Biologics Revenue YoY (2019-2030) & (US$ Million)

Figure 31. Global Respiratory Biologics Sales Share by Manufacturers (2023)

Figure 32. The Respiratory Biologics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 33. Global Respiratory Biologics Revenue Share by Manufacturers (2023)

Figure 34. The Top 5 and 10 Largest Manufacturers of Respiratory Biologics in the World: Market Share by Respiratory Biologics Revenue in 2023

Figure 35. Global Respiratory Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 36. Global Respiratory Biologics Sales Market Share by Type (2019-2030)

Figure 37. Global Respiratory Biologics Revenue Market Share by Type (2019-2030)

Figure 38. Global Respiratory Biologics Sales Market Share by Application (2019-2030)

Figure 39. Global Respiratory Biologics Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Respiratory Biologics Sales Market Share by Type (2019-2030)

Figure 41. US & Canada Respiratory Biologics Revenue Market Share by Type (2019-2030)

Figure 42. US & Canada Respiratory Biologics Sales Market Share by Application (2019-2030)

Figure 43. US & Canada Respiratory Biologics Revenue Market Share by Application (2019-2030)

Figure 44. US & Canada Respiratory Biologics Revenue Share by Country (2019-2030)

Figure 45. US & Canada Respiratory Biologics Sales Share by Country (2019-2030)

Figure 46. US Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 47. Canada Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 48. Europe Respiratory Biologics Sales Market Share by Type (2019-2030)

Figure 49. Europe Respiratory Biologics Revenue Market Share by Type (2019-2030)

Figure 50. Europe Respiratory Biologics Sales Market Share by Application (2019-2030)

Figure 51. Europe Respiratory Biologics Revenue Market Share by Application (2019-2030)

Figure 52. Europe Respiratory Biologics Revenue Share by Country (2019-2030)

Figure 53. Europe Respiratory Biologics Sales Share by Country (2019-2030)

Figure 54. Germany Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 55. France Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 56. U.K. Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 57. Italy Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 58. Russia Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 59. China Respiratory Biologics Sales Market Share by Type (2019-2030)

Figure 60. China Respiratory Biologics Revenue Market Share by Type (2019-2030)

Figure 61. China Respiratory Biologics Sales Market Share by Application (2019-2030)

Figure 62. China Respiratory Biologics Revenue Market Share by Application (2019-2030)

Figure 63. Asia Respiratory Biologics Sales Market Share by Type (2019-2030)

Figure 64. Asia Respiratory Biologics Revenue Market Share by Type (2019-2030)

Figure 65. Asia Respiratory Biologics Sales Market Share by Application (2019-2030)

Figure 66. Asia Respiratory Biologics Revenue Market Share by Application (2019-2030)

Figure 67. Asia Respiratory Biologics Revenue Share by Region (2019-2030)

Figure 68. Asia Respiratory Biologics Sales Share by Region (2019-2030)

Figure 69. Japan Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 70. South Korea Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 71. China Taiwan Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 72. Southeast Asia Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 73. India Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 74. Australia Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 75. Middle East, Africa and Latin America Respiratory Biologics Sales Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Respiratory Biologics Revenue Market Share by Type (2019-2030)

Figure 77. Middle East, Africa and Latin America Respiratory Biologics Sales Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Respiratory Biologics Revenue Market Share by Application (2019-2030)

Figure 79. Middle East, Africa and Latin America Respiratory Biologics Revenue Share by Country (2019-2030)

Figure 80. Middle East, Africa and Latin America Respiratory Biologics Sales Share by Country (2019-2030)

Figure 81. Brazil Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 82. Mexico Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 83. Turkey Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 84. Israel Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 85. GCC Countries Respiratory Biologics Revenue (2019-2030) & (US$ Million)

Figure 86. Respiratory Biologics Value Chain

Figure 87. Respiratory Biologics Production Process

Figure 88. Channels of Distribution (Direct Vs Distribution)

Figure 89. Bottom-up and Top-down Approaches for This Report

Figure 90. Data Triangulation

Figure 91. Key Executives Interviewed

This research report focuses on the Respiratory Biologics Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Respiratory Biologics Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Respiratory Biologics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Intravenous
  • 1.2.3 Subcuteneous
• 1.3 Market by Application
  • 1.3.1 Global Respiratory Biologics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Asthma
  • 1.3.3 Chronic Rhinosinasitis
  • 1.3.4 Hypereosinophilic Syndrome
  • 1.3.5 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Respiratory Biologics Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Respiratory Biologics Revenue by Region
  • 2.2.1 Global Respiratory Biologics Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Respiratory Biologics Revenue by Region (2019-2024)
  • 2.2.3 Global Respiratory Biologics Revenue by Region (2025-2030)
  • 2.2.4 Global Respiratory Biologics Revenue Market Share by Region (2019-2030)
• 2.3 Global Respiratory Biologics Sales Estimates and Forecasts 2019-2030
• 2.4 Global Respiratory Biologics Sales by Region
  • 2.4.1 Global Respiratory Biologics Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Respiratory Biologics Sales by Region (2019-2024)
  • 2.4.3 Global Respiratory Biologics Sales by Region (2025-2030)
  • 2.4.4 Global Respiratory Biologics Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Respiratory Biologics Sales by Manufacturers
  • 3.1.1 Global Respiratory Biologics Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Respiratory Biologics Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Respiratory Biologics in 2023
• 3.2 Global Respiratory Biologics Revenue by Manufacturers
  • 3.2.1 Global Respiratory Biologics Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Respiratory Biologics Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Respiratory Biologics Revenue in 2023
• 3.3 Global Key Players of Respiratory Biologics, Industry Ranking, 2021 VS 2022
• 3.4 Global Respiratory Biologics Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Respiratory Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Respiratory Biologics, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Respiratory Biologics, Product Offered and Application
• 3.8 Global Key Manufacturers of Respiratory Biologics, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Respiratory Biologics Sales by Type
  • 4.1.1 Global Respiratory Biologics Historical Sales by Type (2019-2024)
  • 4.1.2 Global Respiratory Biologics Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Respiratory Biologics Sales Market Share by Type (2019-2030)
• 4.2 Global Respiratory Biologics Revenue by Type
  • 4.2.1 Global Respiratory Biologics Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Respiratory Biologics Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Respiratory Biologics Revenue Market Share by Type (2019-2030)
• 4.3 Global Respiratory Biologics Price by Type
  • 4.3.1 Global Respiratory Biologics Price by Type (2019-2024)
  • 4.3.2 Global Respiratory Biologics Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Respiratory Biologics Sales by Application
  • 5.1.1 Global Respiratory Biologics Historical Sales by Application (2019-2024)
  • 5.1.2 Global Respiratory Biologics Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Respiratory Biologics Sales Market Share by Application (2019-2030)
• 5.2 Global Respiratory Biologics Revenue by Application
  • 5.2.1 Global Respiratory Biologics Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Respiratory Biologics Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Respiratory Biologics Revenue Market Share by Application (2019-2030)
• 5.3 Global Respiratory Biologics Price by Application
  • 5.3.1 Global Respiratory Biologics Price by Application (2019-2024)
  • 5.3.2 Global Respiratory Biologics Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Respiratory Biologics Market Size by Type
  • 6.1.1 US & Canada Respiratory Biologics Sales by Type (2019-2030)
  • 6.1.2 US & Canada Respiratory Biologics Revenue by Type (2019-2030)
• 6.2 US & Canada Respiratory Biologics Market Size by Application
  • 6.2.1 US & Canada Respiratory Biologics Sales by Application (2019-2030)
  • 6.2.2 US & Canada Respiratory Biologics Revenue by Application (2019-2030)
• 6.3 US & Canada Respiratory Biologics Market Size by Country
  • 6.3.1 US & Canada Respiratory Biologics Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Respiratory Biologics Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Respiratory Biologics Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Respiratory Biologics Market Size by Type
  • 7.1.1 Europe Respiratory Biologics Sales by Type (2019-2030)
  • 7.1.2 Europe Respiratory Biologics Revenue by Type (2019-2030)
• 7.2 Europe Respiratory Biologics Market Size by Application
  • 7.2.1 Europe Respiratory Biologics Sales by Application (2019-2030)
  • 7.2.2 Europe Respiratory Biologics Revenue by Application (2019-2030)
• 7.3 Europe Respiratory Biologics Market Size by Country
  • 7.3.1 Europe Respiratory Biologics Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Respiratory Biologics Revenue by Country (2019-2030)
  • 7.3.3 Europe Respiratory Biologics Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Respiratory Biologics Market Size by Type
  • 8.1.1 China Respiratory Biologics Sales by Type (2019-2030)
  • 8.1.2 China Respiratory Biologics Revenue by Type (2019-2030)
• 8.2 China Respiratory Biologics Market Size by Application
  • 8.2.1 China Respiratory Biologics Sales by Application (2019-2030)
  • 8.2.2 China Respiratory Biologics Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Respiratory Biologics Market Size by Type
  • 9.1.1 Asia Respiratory Biologics Sales by Type (2019-2030)
  • 9.1.2 Asia Respiratory Biologics Revenue by Type (2019-2030)
• 9.2 Asia Respiratory Biologics Market Size by Application
  • 9.2.1 Asia Respiratory Biologics Sales by Application (2019-2030)
  • 9.2.2 Asia Respiratory Biologics Revenue by Application (2019-2030)
• 9.3 Asia Respiratory Biologics Market Size by Region
  • 9.3.1 Asia Respiratory Biologics Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Respiratory Biologics Revenue by Region (2019-2030)
  • 9.3.3 Asia Respiratory Biologics Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Respiratory Biologics Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Respiratory Biologics Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Respiratory Biologics Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Respiratory Biologics Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Respiratory Biologics Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Respiratory Biologics Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Respiratory Biologics Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Respiratory Biologics Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Respiratory Biologics Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Respiratory Biologics Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 GSK
  • 11.1.1 GSK Company Information
  • 11.1.2 GSK Overview
  • 11.1.3 GSK Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 GSK Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 GSK Recent Developments
• 11.2 AstraZeneca
  • 11.2.1 AstraZeneca Company Information
  • 11.2.2 AstraZeneca Overview
  • 11.2.3 AstraZeneca Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 AstraZeneca Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 AstraZeneca Recent Developments
• 11.3 Sanofi
  • 11.3.1 Sanofi Company Information
  • 11.3.2 Sanofi Overview
  • 11.3.3 Sanofi Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Sanofi Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Sanofi Recent Developments
• 11.4 Genentech USA
  • 11.4.1 Genentech USA Company Information
  • 11.4.2 Genentech USA Overview
  • 11.4.3 Genentech USA Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Genentech USA Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Genentech USA Recent Developments
• 11.5 Teva Respiratory
  • 11.5.1 Teva Respiratory Company Information
  • 11.5.2 Teva Respiratory Overview
  • 11.5.3 Teva Respiratory Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Teva Respiratory Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Teva Respiratory Recent Developments
• 11.6 Novartis
  • 11.6.1 Novartis Company Information
  • 11.6.2 Novartis Overview
  • 11.6.3 Novartis Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Novartis Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Novartis Recent Developments
• 11.7 Roche
  • 11.7.1 Roche Company Information
  • 11.7.2 Roche Overview
  • 11.7.3 Roche Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Roche Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Roche Recent Developments
• 11.8 Boehringer Ingelheim
  • 11.8.1 Boehringer Ingelheim Company Information
  • 11.8.2 Boehringer Ingelheim Overview
  • 11.8.3 Boehringer Ingelheim Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Boehringer Ingelheim Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Boehringer Ingelheim Recent Developments
• 11.9 Regeneron Pharmaceuticals
  • 11.9.1 Regeneron Pharmaceuticals Company Information
  • 11.9.2 Regeneron Pharmaceuticals Overview
  • 11.9.3 Regeneron Pharmaceuticals Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Regeneron Pharmaceuticals Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Regeneron Pharmaceuticals Recent Developments
• 11.10 Merck
  • 11.10.1 Merck Company Information
  • 11.10.2 Merck Overview
  • 11.10.3 Merck Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Merck Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Merck Recent Developments
• 11.11 Johnson & Johnson
  • 11.11.1 Johnson & Johnson Company Information
  • 11.11.2 Johnson & Johnson Overview
  • 11.11.3 Johnson & Johnson Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Johnson & Johnson Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Johnson & Johnson Recent Developments
• 11.12 Amgen
  • 11.12.1 Amgen Company Information
  • 11.12.2 Amgen Overview
  • 11.12.3 Amgen Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Amgen Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Amgen Recent Developments
• 11.13 Biogen
  • 11.13.1 Biogen Company Information
  • 11.13.2 Biogen Overview
  • 11.13.3 Biogen Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.13.4 Biogen Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Biogen Recent Developments
• 11.14 Vertex Pharmaceuticals
  • 11.14.1 Vertex Pharmaceuticals Company Information
  • 11.14.2 Vertex Pharmaceuticals Overview
  • 11.14.3 Vertex Pharmaceuticals Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.14.4 Vertex Pharmaceuticals Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Vertex Pharmaceuticals Recent Developments
• 11.15 AbbVie
  • 11.15.1 AbbVie Company Information
  • 11.15.2 AbbVie Overview
  • 11.15.3 AbbVie Respiratory Biologics Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.15.4 AbbVie Respiratory Biologics Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 AbbVie Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Respiratory Biologics Industry Chain Analysis
• 12.2 Respiratory Biologics Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Respiratory Biologics Production Mode & Process
• 12.4 Respiratory Biologics Sales and Marketing
  • 12.4.1 Respiratory Biologics Sales Channels
  • 12.4.2 Respiratory Biologics Distributors
• 12.5 Respiratory Biologics Customers

13 Respiratory Biologics Market Dynamics

• 13.1 Respiratory Biologics Industry Trends
• 13.2 Respiratory Biologics Market Drivers
• 13.3 Respiratory Biologics Market Challenges
• 13.4 Respiratory Biologics Market Restraints

14 Key Findings in the Global Respiratory Biologics Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer